Navigation Links
Nanofibers from Biopolymers at the BIO International Convention in Chicago
Date:4/23/2013

Chicago, Illinois (PRWEB) April 23, 2013

In Chicago this week, Contipro Biotech, a European company, is presenting its nanotechnology device, 4SPIN, capable of preparing nano-materials from biopolymers. Thanks to this device, company expects a significant increase in new applications of biomaterials in biotech and medicine.

Why nanofibers?
Nanofibers are thousands of times finer than a human hair. Their small magnitude is ideal for many amazing applications where conventional materials are unable to achieve a comparable result. These include filtration, where the tiny pores of nanofibers can prevent the passage of viruses and bacteria, and utilization of huge surface areas of nanofibers, made possible by their slight volume. A great future is also projected in electronics, energy, optics, defence and environmental applications.

Why from biopolymers?
However, as the price of producing nano-materials remains higher than that of conventional materials, the most widespread application is expected where the benefits of nano-materials significantly outweigh their higher price. In this respect, it is also claimed that approximately two thirds of new nano-applications will be in pharmacy and medicine. This is why nanofibers from biocompatible polymers are so interesting.

Nanofibers from biopolymers can be used, for example, to create scaffolding as support for cells in the production of new tissues. Well-designed scaffolding provides support for cells and gives them signals about how to organize and develop, and how to create a graft to replace the patient’s damaged tissue. Then, on completion of the healing process, all support components are fully absorbed. An important aspect which plays a major role in determining the future development of new applications for medicine will be the ability to create the necessary structures and materials from the human body’s own substances.

About the device:
4SPIN is a high-tech electrospinning device that relies on electronic rather than manual control. Apart from the emphasis on the ability of fibrous and difficult-to-process materials, it is characterized by a high degree of operating safety. It is universally applicable, including preparation for placement in clean rooms, thus also facilitating research into medical nano-applications. A laboratory device will soon complement the pilot-operational and operational version of the apparatus.

Read the full story at http://www.prweb.com/releases/2013/4/prweb10656376.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Join Cato BioVentures at BIO International Convention
2. Oramed CEO to be Panelist at BIO International Convention Breakout Session on Israel Becoming Biotech Leader
3. Trigemina to Present at the 2013 BIO International Convention
4. Infinata’s BioPharm Insight to Offer Exclusive Preview of 2013 Key Reports at the BIO International Conference and Partnerships in Clinical Trials
5. Campbell Alliance to Release New Forward-Looking Industry Report on Deal-Making Trends at the 2013 BIO International Convention
6. 20 Swiss Biotech Firms and Organizations will Populate the Swiss Pavilion at BIO 2013 International Convention
7. Blood-Based Circulating Microvesicles (cMV) Data to be Presented at the 2013 International Society for Extracellular Vesicles (ISEV)
8. Dyadic International To Speak At Advanced Biofuels Leadership Conference Panel Discussion
9. Janssen Announces Data from Simeprevir in Hepatitis C Patients Will Be Presented at The International Liver Congress of the European Association for the Study of the Liver (EASL)
10. Nerium International Receives the 2012 Global 100 Bravo Award for Growth
11. 31st International Symposium on Lattice Field Theory
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , ... June 23, 2016 , ... ... release of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering ... retention in this eBook by providing practical tips, tools, and strategies for clinical ...
(Date:6/23/2016)... June 23, 2016 /PRNewswire/ - FACIT has announced ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" ... commercialization of a portfolio of first-in-class WDR5 inhibitors ... such as WDR5 represent an exciting class of ... precision medicine for cancer patients. Substantial advances have ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... YM (Yeast and Mold) microbial test has received AOAC Research Institute approval 061601. ... microbial tests introduced last year,” stated Bob Salter, Vice President of Regulatory and ...
(Date:6/23/2016)... 23, 2016   EpiBiome , a precision microbiome ... in debt financing from Silicon Valley Bank (SVB). The ... to advance its drug development efforts, as well as ... "SVB has been an incredible strategic partner to ... traditional bank would provide," said Dr. Aeron Tynes ...
Breaking Biology Technology:
(Date:4/13/2016)... , April 13, 2016  IMPOWER physicians supporting ... are setting a new clinical standard in telehealth thanks ... By leveraging the higi platform, IMPOWER patients can routinely ... pulse and body mass index, and, when they opt ... and convenient visit to a local retail location at ...
(Date:3/29/2016)... 2016 LegacyXChange, Inc. (OTC: ... SelectaDNA/CSI Protect are pleased to announce our successful effort ... variety of writing instruments, ensuring athletes signatures against counterfeiting ... from athletes on LegacyXChange will be assured of ongoing ... Bill Bollander , CEO states, "By ...
(Date:3/22/2016)... and SANDY, Utah , March ... operates the highest sample volume laboratory in ... and UNIConnect, leaders in clinical sequencing informatics and molecular ... of a project to establish the informatics infrastructure for ... NSO has been contracted by the Ontario Ministry ...
Breaking Biology News(10 mins):